Facts

Contact person:
Rita Del Giudice
Financer:
  • The Mats Paulsson Foundations
Responsible at MaU:
Rita Del Giudice
Project members at MaU:
Time frame:
01 January 2027 - 31 December 2029
Research subject:

About the project

Cardiovascular disease remains a global killer. Current drugs effectively lower “bad” cholesterol, but many patients still face high risks due to persistent vessel inflammation. Imagine a treatment that does not just lower bad cholesterol but also actively repairs and protects our arteries. Our research uses protein engineering to build an enhanced, lab-grown version of “good” HDL cholesterol. By redesigning the proteins that protect our blood vessels, we are creating a therapeutic platform that protects blood vessels from damage and inflammation. Our goal is to provide a life-saving solution for high-risk patients who are not protected by today's standard treatments.